PBS funding for MHT patches 'at risk', doctors say

Transdermal patches could be pulled from the PBS if the manufacturer's bid for a price hike is declined

Women’s health advocates are fighting to keep several menopausal hormone therapy products on the PBS — including the only two remaining combined transdermal patches  after a bid to delist them.

Dr Karen Magraith.

The supplier of Estradot (oestradiol) and Estalis (oestradiol and norethisterone), Sandoz (a division of Novartis), applied to the PBAC

Latest